<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ900622-0073</DOCNO><DOCID>900622-0073.</DOCID><HL>   Who's News:   Celgene Names Ufheil   To Succeed Fernandez   As President and Chief</HL><DATE>06/22/90</DATE><SO>WALL STREET JOURNAL (J), PAGE B4</SO><CO>   CELG WNEWS</CO><LP>   WARREN, N.J. -- John L. Ufheil was named president andchief executive officer of Celgene Corp., succeeding LouisFernandez in those posts. Mr. Fernandez was named chairman ofthe biotechnology concern but expects to retire next year.   Mr. Ufheil, 56 years old, is the former chief operatingofficer of Mallinckrodt Inc., a medical products andspecialty chemicals unit of International Minerals andChemical Corp., Northbrook, Ill. A company spokesman said thechange in leadership is part of a transition planned by Mr.Fernandez, 66, when he became president of Celgene at thecompany's inception in 1986. Celgene was spun off from theformer Celanese Corp. before it merged with the U.S. unit ofHoechst AG of West Germany. Mr. Fernandez, the spokesmansaid, plans to retire from Celgene next year.</LP><TEXT>   Frank T. Cary, who has been chairman, was named chairmanof a new executive committee of the board. Mr. Cary is aformer chairman of International Business Machines Corp.   Celgene develops specialty chemicals and processeshazardous waste. It reported revenue of about $3 million lastyear, derived from research contracts and interest earned.</TEXT></DOC>